Table 1.
Characteristics of enrolled subjects. Each letter of the participant ID designates an individual, while numbers represent dose and day of sampling, respectively.
| Participant ID | Age (Years) | Sex | Vaccine | Doses Received | Time (Days) | |||
|---|---|---|---|---|---|---|---|---|
| Between Doses | Blood Collection after 1st Dose | Blood Collection after 2nd Dose | Blood Collection after 3rd Dose | |||||
| A1.1 | 37 | M | BNT162b2 | 1 | 1 | |||
| B1.1 | 49 | F | BNT162b2 | 1 | 1 | |||
| C1.2 | 37 | M | BNT162b2 | 1 | 2 | |||
| D1.3 | 21 | F | BNT162b2 | 1 | 3 | |||
| E1.3 | 21 | M | BNT162b2 | 1 | 3 | |||
| F1.4 | 21 | F | BNT162b2 | 1 | 4 | |||
| G1.4 | 21 | M | BNT162b2 | 1 | 4 | |||
| H1.5 | 33 | F | BNT162b2 | 1 | 5 | |||
| I1.6 | 21 | F | BNT162b2 | 1 | 6 | |||
| G1.6 | 21 | M | BNT162b2 | 1 | 6 | |||
| H2.0 | 33 | F | BNT162b2 | 2 | 21 | 0 | ||
| J2.1 | 37 | F | BNT162b2 | 2 | 21 | 1 | ||
| B2.2 | 49 | F | BNT162b2 | 2 | 21 | 2 | ||
| K2.2 | 50 | F | BNT162b2 | 2 | 21 | 2 | ||
| J2.2 | 37 | F | BNT162b2 | 2 | 21 | 2 | ||
| C2.3 | 37 | M | BNT162b2 | 2 | 21 | 3 | ||
| L2.3 | 37 | M | BNT162b2 | 2 | 21 | 3 | ||
| M2.5 | 25 | F | BNT162b2 | 2 | 21 | 5 | ||
| N2.5 | 34 | F | BNT162b2 | 2 | 21 | 5 | ||
| O2.6 | 35 | F | BNT162b2 | 2 | 21 | 6 | ||
| P2.7 | 21 | F | BNT162b2 | 2 | 21 | 7 | ||
| B2.15 | 49 | F | BNT162b2 | 2 | 21 | 15 | ||
| M2.27 | 25 | F | BNT162b2 | 2 | 21 | 27 | ||
| CTRL1 | 31 | M | ||||||
| CTRL2 | 68 | F | ||||||
| CTRL3 | 39 | M | ||||||
| B3 | 49 | F | BNT162b2 | 3 | 21/272 | 0, 1, 2, 4, 7, 9, 11, 14 | ||